Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study

Cited by (1,000)

Items 801–900 of 1,000

1. Differential gene expression in human tissue resident regulatory T cells from lung, colon, and blood
   Magdalena Niedzielska, Elisabeth Israelsson, B. Angermann, Ben S. Sidders, Maryam Clausen, Matthew C. Catley, Rajneesh Malhotra, Céline Dumont · 2018 · Oncotarget
2. Multiple sclerosis: getting personal with induced pluripotent stem cells
   Annalisa Di Ruscio, Francesco Patti, Robert S. Welner, Daniel Geoffrey Tenen, Giovanni Amabile · 2015 · Cell Death and Disease
3. IL2RA Genetic Variants Reduce IL-2–Dependent Responses and Aggravate Human Cutaneous Leishmaniasis
   Pablo Rafael Silveira Oliveira, Hélia Dessein, Audrey Romano, Sandrine Cabantous, Maria E. F. de Brito, F Santoro, Maíra Galdino da Rocha Pitta, Valéria Rêgo Alves Pereira, Lain Carlos Pontes-de-Carvalho, Virmondes Rodrigues et al. · 2015 · The Journal of Immunology
4. An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1gene
   Sreeram V. Ramagopalan, Róisín M. McMahon, David Alexandre Dyment, Adele Dessa Sadovnick, George C. Ebers, Knut M. Wittkowski · 2009 · BMC Medical Genetics
5. Autoimmunity since the 1957 clonal selection theory: a little acorn to a large oak
   Ian R Mackay · 2007 · Immunology and Cell Biology
6. The Clark Phaseable Sample Size Problem: Long-Range Phasing and Loss of Heterozygosity in GWAS
   Bjarni V. Halldórsson, Derek Aguiar, Ryan Tarpine, Sorin Istrail · 2011 · Journal of Computational Biology
7. Biomarkers in Multiple Sclerosis
   Roland Martinꝉ, Bibiana Bielekova, Reinhard Hohlfeld, Ursula Utz · 2006 · Disease Markers
8. A genetic basis for multiple sclerosis severity: Red herring or real?
   Vilija Jokubaitis, Helmut Butzkueven · 2016 · Molecular and Cellular Probes
9. Chronobiological regulation of psychosocial and physiological outcomes in multiple sclerosis
   Elisea De Somma, Rajiv W. Jain, Kelvin W. C. Poon, Kaitlyn A. Tresidder, Julia P. Segal, Nader Ghasemlou · 2018 · Neuroscience & Biobehavioral Reviews
10. Involvement of Genetic Factors in Multiple Sclerosis
    Laura Ferrè, Massimo Filippi, Federica Esposito · 2020 · Frontiers in Cellular Neuroscience
11. Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects
    Yingfang Tian, Michelle Apperson, Bradley P. Ander, Dazhi Liu, Boryana S. Stomova, Glen C. Jickling, Richelle Enriquez, Mark A Agius, Frank R. Sharp · 2010 · Journal of Neuroimmunology
12. Epidemiology and diagnosis of multiple sclerosis
    Ghaniah Hassan‐Smith, Michael R. Douglas · 2011 · British Journal of Hospital Medicine
13. Decreased serum levels of nucleolin protein fragment, as analyzed by bead-based proteomic technology, in multiple sclerosis patients compared to controls
    Jianghong Liu, Linlin Yin, Huiqing Dong, Erhe Xu, Lan Zhang, Yuchen Qiao, Yuan Liu, Lin Li, Jianping Jia · 2012 · Journal of Neuroimmunology
14. Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals
    Jean Shin, Céline Bourdon, Manon Bernard, Michael D. Wilson, Eva Reischl, Mélanie Waldenberger, Barbara Ruggeri, Günter Schumann, Sylvane Desrivières, Alexander Leemans et al. · 2015 · Human Molecular Genetics
15. Investigating the Causal Effect of Brain Expression of CCL2, NFKB1, MAPK14, TNFRSF1A, CXCL10 Genes on Multiple Sclerosis: A Two-Sample Mendelian Randomization Approach
    Teresa Fazia, Andrea Nova, Davide Gentilini, Ashley Harris Beecham, Marialuisa Piras, Valeria Saddi, Anna Ticca, Pierpaolo Bitti, Jacob L. McCauley, Carlo Berzuini et al. · 2020 · Frontiers in Bioengineering and Biotechnology
16. Polymorphisms in the Inflammatory Genes CIITA, CLEC16A and IFNG Influence BMD, Bone Loss and Fracture in Elderly Women
    Maria Swanberg, Fiona E. McGuigan, Kaisa K. Ivaska, Paul Gerdhem, Kristina Åkesson · 2012 · PLoS ONE
17. Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency
    Ricardo F. Frausto, Stephen J. Crocker, Boreth Eam, Jason K. Whitmire, J. Lindsay Whitton · 2007 · Journal of Neuroimmunology
18. Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: Proteomic analysis
    Setsu Sawai, Hiroshi Umemura, Masahiro Mori, Mamoru Satoh, Sei Hayakawa, Yoshio Kodera, Takeshi Tomonaga, Satoshi Kuwabara, Fumio Nomura · 2009 · Journal of Neuroimmunology
19. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study
    Jing-Shan Wu, IAN R. JAMES, Wei Qiu, Alison S. L. Castley, Frank Christiansen, William M Carroll, Frank Louis Mastaglia, Allan G. Kermode · 2010 · Multiple Sclerosis Journal
20. Involvement of CLEC16A in Activation of Astrocytes After LPS Treated
    Xinmin Wu, Jing Li, Chun Chen, Yaohua Yan, Shengyang Jiang, Xiaohong Wu, Bai Shao, Jin Xu, Lihua Kang, Yeqing Huang et al. · 2011 · Neurochemical Research
21. Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis
    Soheil Tavakolpour · 2016 · Multiple Sclerosis and Related Disorders
22. Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis
    Yvonne Benešová, Anna Vašků, Julie Bienertová Vašků · 2018 · Acta Neurologica Belgica
23. The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle
    Noha Salah Elsayed, Paula Aston, Vishnu R. Bayanagari, Sanjay K. Shukla · 2022 · Frontiers in Immunology
24. Biochemical biomarkers for multiple sclerosis
    Julia Maroto‐García, Ana Martínez‐Escribano, Virginia Delgado Gil, Minerva Mañez, Carmen Mugueta, Nerea Varo, A García-de la Torre, Maximiliano Ruiz‐Galdón · 2023 · Clinica Chimica Acta
25. Immunogenetic Mechanisms Leading to Thyroid Autoimmunity: Recent Advances in Identifying Susceptibility Genes and Regions
    O. Brand, S. Gough · 2011 · Current Genomics
26. Identification of Novel Single Nucleotide Polymorphisms in Inflammatory Genes as Risk Factors Associated with Trachomatous Trichiasis
    Berna Atik, Troy Skwor, Ram Prasad Kandel, Bassant Sharma, Him Kant Adhikari, Lori L. Steiner, Henry Erlich, Deborah Dean · 2008 · PLoS ONE
27. Closing the gap between genotype and phenotype
    Peter K. Gregersen · 2009 · Nature Genetics
28. Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis
    Marie‐Claude Babron, Hervé Perdry, Adam E. Handel, Sreeram V. Ramagopalan, Vincent Damotte, Bertrand Fontaine, Bertram Müller‐Myhsok, George C. Ebers, Françoise Clerget‐Darpoux · 2011 · European Journal of Human Genetics
29. Gut Commensalism, Cytokines, and Central Nervous System Demyelination
    Kiel M. Telesford, Javier Ochoa‐Repáraz, Lloyd H. Kasper · 2014 · Journal of Interferon & Cytokine Research
30. Activation of myelin reactive T cells in multiple sclerosis: A possible role for T cell degeneracy?
    Piet Stinissen, Niels Hellings · 2008 · European Journal of Immunology
31. Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome
    Tomáš Kalinčík, Charles R.G. Guttmann, Jan Krásenský, Manuela Vaněčková, Petra Lelková, Michaela Týblová, Zdeněk Seidl, Philip L. De Jager, Eva Havrdová, Dana Horáková · 2013 · Genes and Immunity
32. Polymorphisms at 16p13 are associated with systemic lupus erythematosus in the Chinese population: Table 1
    Zheng Zhang, Yilin Cheng, Xueya Zhou, Y. Li, Jinping Gao, Jianwen Han, Cheng Quan, Shan He, Yongmei Lv, D. Hu et al. · 2010 · Journal of Medical Genetics
33. Perspectives on the Use of Multiple Sclerosis Risk Genes for Prediction
    Naghmeh Jafari, Linda Broer, Cornelia M. van Duijn, A. Cecile J.W. Janssens, Rogier Q. Hintzen · 2011 · PLoS ONE
34. Shared Genetic Etiology of Autoimmune Diseases in Patients from a Biorepository Linked to De-identified Electronic Health Records
    NICOLE A. RESTREPO, Mariusz Butkiewicz, Josephine A. McGrath, Dana C. Crawford · 2016 · Frontiers in Genetics
35. Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease
    Yuichiro Itoh, Rhonda R. Voskuhl · 2017 · PLoS ONE
36. Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family
    Julia Y. Mescheriakova, Annemieke J.M.H. Verkerk, Najaf Amin, André Gerardus Uitterlinden, Cornelia M. van Duijn, Rogier Q. Hintzen · 2018 · Multiple Sclerosis Journal
37. Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
    Francesca Gado, Maria Digiacomo, Marco Macchia, Simone Bertini, Clementina Manera · 2018 · Medicines
38. CLEC16A regulates splenocyte and NK cell function in part through MEK signaling
    Rahul Pandey, Marina A. Bakay, Heather S. Hain, Bryan P. Strenkowski, Barakat Elsaqa, Jeffrey D. Roizen, Jake A. Kushner, Jordan Scott Orange, Hakon H. Hakonarson · 2018 · PLoS ONE
39. Vitamin D and Demyelinating Diseases: Neuromyelitis Optica (NMO) and Multiple Sclerosis (MS)
    Cady Rodney, Sherriann Rodney, Richard Mark Millis · 2020 · Autoimmune Diseases
40. Fine Mapping and Functional Studies of Risk Variants for Type 1 Diabetes at Chromosome 16p13.13
    M. Joseph Tomlinson, Achilleas Pitsillides, Rebecca Roche Pickin, Matthew Mika, Keith L. Keene, Xuanlin Hou, Josyf C. Mychaleckyj, Wei‐Min Chen, PATRICK J. CONCANNON, Suna Önengüt-Gümüşcü · 2014 · Diabetes
41. Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12 566 individuals
    Farren B. S. Briggs, Selena E. Bartlett, Benjamin Alan Goldstein, Joanne Wang, Jacob L. McCauley, Rebecca L. Zuvich, Philip L. De Jager, John David Rioux, Adrian J. Ivinson, Alastair Compston et al. · 2010 · Human Molecular Genetics
42. Efficient Genome-wide Association in Biobanks Using Topic Modeling Identifies Multiple Novel Disease Loci
    Thomas H. McCoy, Victor Manuel Castro, Leslie A. Snapper, Kamber L. Hart, Roy H. Perlis · 2017 · Molecular Medicine
43. Visual loss
    Grant T. Liu, Nicholas J. Volpe, Steven L. Galetta · 2010 · Elsevier eBooks
44. Novel somatic single nucleotide variants within the RNA binding protein hnRNP A1 in multiple sclerosis patients.
    Sangmin Lee, Michael C. Levin · 2014 · PubMed Central
45. Human IL-6R hi TIGIT − CD4 + CD127 low CD25 + T cells display potent in vitro suppressive capacity and a distinct Th17 profile
    Ferreira, Ricardo C., Rainbow, Daniel B., Rubio García, Arcadio, Pekalski, Marcin L., Porter, Linsey, Oliveira, João J., Waldron-Lynch, Frank, Wicker, Linda S., Todd, John A. · 2017 · Clinical Immunology
46. Multiple sclerosis: Motor dysfunction
    David S. Younger · 2023 · Handbook of clinical neurology
47. Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs
    Corey T. Watson, Giulio Disanto, Felix J. Breden, Gavin Giovannoni, Sreeram V Ramagopalan · 2012 · Scientific Reports
48. Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis
    Mehrdad Farrokhi, Mehrnoosh Dabirzadeh, Elyas Fadaee, Ali Amani-Beni, Zahra Saadatpour, Ali Rezaei, Zahra Heidari · 2016 · Immunological Investigations
49. Cytotoxicity - Understanding Cellular Damage and Response
    Anil Sukumaran, Mahmoud Ahmed Mansour · 2022 · IntechOpen eBooks
50. VISUAL INTEGRATION OF RESULTS FROM A LARGE DNA BIOBANK (BIOVU) USING SYNTHESIS-VIEW
    Sarah A. Pendergrass, SCOTT M. DUDEK, Dan M. Roden, Dana C. Crawford, Marylyn DeRiggi Ritchie · 2010 · WORLD SCIENTIFIC eBooks
51. The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort
    Wei Qiu, Kym Pham, IAN R. JAMES, David A Nolan, Allison Castley, Frank Christiansen, Petra Czarniak, Yue‐Bei Luo, Jing-Shan Wu, Michael J. Garlepp et al. · 2013 · Journal of Neuroimmunology
52. Genetic Factors of Autoimmune Thyroid Diseases in Japanese
    Yoshiyuki Ban · 2011 · Autoimmune Diseases
53. A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility
    Alessandro Bonetti, Keijo J. Koivisto, Tuula Pirttilä, Irina Elovaara, Mauri Reunanen, Mikko Laaksonen, Juhani Ruutiainen, Leena Peltonen, Terhi Rantamäki, Pentti J. Tienari · 2009 · Journal of Neuroimmunology
54. CD8-mediated inflammatory central nervous system disorders
    Anne Willing, Manuel Alexander Friese · 2012 · Current Opinion in Neurology
55. Novel UBE2B-associated polymorphisms in an azoospermic/oligozoospermic population
    Ivan Huang, Benjamin R. Emery, Greg L. Christensen, Jeanine Griffin, C. Matthew Peterson, Douglas T. Carrell · 2008 · Asian Journal of Andrology
56. Genetics in primary sclerosing cholangitis
    Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, André Franke, Tom H. Karlsen · 2012 · Clinics and Research in Hepatology and Gastroenterology
57. Methylation of class II transactivator gene promoter IV is not associated with susceptibility to Multiple Sclerosis
    Sreeram V. Ramagopalan, David Alexandre Dyment, Katie Morrison, Blanca M. Herrera, Gabriele Carmine DeLuca, Matthew R. Lincoln, Sarah M. Orton, Lahiru Handunnetthi, Michael J. Chao, Adele Dessa Sadovnick et al. · 2008 · BMC Medical Genetics
58. Nicotinic Acid‐Mediated Activation of Both Membrane and Nuclear Receptors towards Therapeutic Glucocorticoid Mimetics for Treating Multiple Sclerosis
    William Todd Penberthy · 2009 · PPAR Research
59. Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes
    Adrián Cortés, Judith Field, Evgeny A. Glazov, Johanna Hadler, Jim M. Stankovich, Matthew Arthur Brown, A. Baxter, Allan G. Kermode, Bruce V. Taylor, David Richmond Booth et al. · 2013 · Human Molecular Genetics
60. A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome
    Alessandro Didonna, Noriko Isobe, Stacy J. Caillier, Kathy H. Li, Alma L. Burlingame, Stephen L. Hauser, Sergio E. Baranzini, Nikolaos A. Patsopoulos, Jorge R. Oksenberg · 2015 · Human Molecular Genetics
61. European multiple sclerosis risk variants in the south Asian population
    Lekha Pandit, Maria Ban, Ashley Harris Beecham, Jacob L. McCauley, Stephen J. Sawcer, Anitha D’Cunha, Chaithra Malli, Omar Malik · 2016 · Multiple Sclerosis Journal
62. The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis
    Nadia Ben Fredj, K. Sakly, Daria Bortolotti, Mouna Aissi, Mahbouba Frih-Ayed, Antonella Rotola, Elisabetta Caselli, Franscesca Cura, Nabil Sakly, Mahjoub Aouni et al. · 2016 · Immunology Letters
63. Insights into the Role of Neuroinflammation in the Pathogenesis of Multiple Sclerosis
    Ghaith Al‐Badri, Alessandro Castorina · 2018 · Journal of Functional Morphology and Kinesiology
64. Cutting Edge: The Idd3 Genetic Interval Determines Regulatory T Cell Function through CD11b+CD11c− APC
    Ana Carrizosa Anderson, Rucha Chandwaskar, David H. Lee, Vijay Kumar Kuchroo · 2008 · The Journal of Immunology
65. Decreased 4-1BB expression on CD4+CD25high regulatory T cells in peripheral blood of patients with multiple sclerosis
    G-Z Liu, A C Gomes, L-B Fang, X.‐G. Gao, Peter Hjelmström · 2008 · Clinical & Experimental Immunology
66. Interaction of HLA-DRB1*1501 allele and TNF-alpha −308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis
    Majid Shahbazi, Danial Roshandel, Eskandar omidnyia, Azam Rshaidbaghan · 2011 · Clinical Immunology
67. The role of KIR2DS1 in multiple sclerosis - KIR in Portuguese MS patients
    Andreia Bettencourt, ANA CESARINA FERREIRA DA SILVA, Cláudia Carvalho, Bárbara Leal, Ernestina Santos, Paulo Costa, Berta Martins da Silva · 2014 · Journal of Neuroimmunology
68. Chronic autoimmune-mediated inflammation: a senescent immune response to injury
    Bert A. ‘t Hart, Paulina Chalan, Gerrit Koopman, Annemieke M. H. Boots · 2012 · Drug Discovery Today
69. Copy number variations in multiple sclerosis and neuromyelitis optica
    Shinya Sato, Ken Yamamoto, Takuya Matsushita, Noriko Isobe, Yuji Kawano, Kyoko Iinuma, Masaaki Niino, Toshiyuki Fukazawa, Yuri Nakamura, Mitsuru Watanabe et al. · 2015 · Annals of Neurology
70. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease
    Diego Iacono, Shunsuke Koga, Hui Chin Peng, Arulmani Manavalan, Jessica Daiker, Monica Castanedes‐Casey, Nicholas B. Martin, Aimee R. Herdt, Michael H. Gelb, Dennis W. Dickson et al. · 2022 · Neurobiology of Disease
71. Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
    Lorena Lorefice, Maristella Pitzalis, Federica Murgia, Giuseppe Fenu, Luigi Atzori, Eleonora E. Cocco · 2023 · Frontiers in Genetics
72. A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
    Lizhong Wang, Runhua Liu, Dongling Li, Shili Lin, Xianfeng Fang, Grant Backer, Mandy Kain, Kottil Rammoham, Pan Zheng, Yang Liu · 2012 · Europe PMC (PubMed Central)
73. RNA profiling of MS brain tissues.
    Jochen Kinter, Thomas Zeis, Nicole Schaeren‐Wiemers · 2008 · PubMed
74. Sudden Cardiac Death: The Larger Problem… the Larger Genome
    Peter M. Spooner · 2009 · Journal of Cardiovascular Electrophysiology
75. Inhibition of Glyceraldehyde-3-Phosphate Dehydrogenase Activity by Antibodies Present in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
    Johanna Kolln, Yiping Zhang, G. Thai, Michael A. Demetriou, N. Hermanowicz, P. Duquette, S. van den Noort, Yu-Fen Qin · 2010 · Journal of Immunology
76. The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities
    Douglas S. Goodin · 2016 · BMC Neurology
77. HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family
    Lorena Mosca · 2017 · Functional Neurology
78. Identification of novel susceptibility genes associated with seven autoimmune disorders using whole genome molecular interaction networks
    Sam Kara, Gerardo A. Pirela-Morillo, T. Conrad Gilliam, George David Wilson · 2018 · Journal of Autoimmunity
79. The Autoimmune Disorder Susceptibility Gene CLEC16A Restrains NK Cell Function in YTS NK Cell Line and Clec16a Knockout Mice
    Rahul Pandey, Marina A. Bakay, Heather S. Hain, Bryan P. Strenkowski, Anastasiya Yermakova, Jake A. Kushner, Jordan Scott Orange, Hakon H. Hakonarson · 2019 · Frontiers in Immunology
80. Multiple sclerosis in Colombia and other Latin American Countries
    Jaime Toro, Simón Cárdenas‐Robledo, Carlos Martínez, Julián Urrutia, Camilo Díaz · 2012 · Multiple Sclerosis and Related Disorders
81. Interleukin 2 Receptor α Gene Polymorphism and Risk of Multiple Sclerosis: A Meta-Analysis
    LM Wang, D-M Zhang, Y-M Xu, S-L Sun · 2011 · Journal of International Medical Research
82. The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences
    Alan Ebringer, Taha Rashid, Clyde Wilson · 2012 · Medical Hypotheses
83. Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS
    Konstantinos Aggelakis, Fani Zacharaki, Efthimios Dardiotis, Georgia Xiromerisiou, Vana Tsimourtou, Styliani Ralli, Maria Gkaraveli, Dimitris Bourpoulas, Paraskevi Rodopoulou, Alexandros Papadimitriou et al. · 2009 · Neurological Sciences
84. Opposing roles of endothelial and leukocyte-expressed IL-7Rα in the regulation of psoriasis-like skin inflammation
    Martina Vranova, Mona C. Friess, Neda Haghayegh Jahromi, Víctor Collado‐Díaz, Angela Vallone, Olivia Hagedorn, Maria Jadhav, Ann‐Helen Willrodt, Anna K. Polomska, Jean‐Christophe Leroux et al. · 2019 · Scientific Reports
85. HLA Class I–Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine
    Gilles Bioley, Philippe Guillaume, Immanuel F. Luescher, Alice Yeh, Bo Dupont, Nina Bhardwaj, Gregory Mears, Lloyd J. Old, Danila Valmori, Maha Ayyoub · 2008 · Clinical Cancer Research
86. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility
    Ana Márquez, María Carmen Cénit, C Núñez, Juan L. Mendoza, Carlos Taxonera, Maria Elena Diaz-Rubio, M. Bartolomé, R Arroyo, Miguel Fernández‐Arquero, Emilio G. de la Concha et al. · 2009 · Genes and Immunity
87. Multiple sclerosis as a polygenic disease: An update
    Olga O. Favorova, О. Г. Кулакова, А. Н. Бойко · 2010 · Russian Journal of Genetics
88. Association analysis of PARK16-18 variants and Parkinson’s disease in a Chinese population
    Lili Zhou, Xiong Zhang, Qiongqiong Bao, Rong‐Pei Liu, Mei-Ying Gong, Guangyun Mao, Ming Zou, Jian‐Hong Zhu · 2013 · Journal of Clinical Neuroscience
89. Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis
    Kathrine E. Attfield, Calliope Athena Dendrou, Lars H. Fugger · 2012 · Immunological Reviews
90. TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis
    Carlos Lopez Gomez, Óscar Fernández, Juan Antonio García‐León, María Jesús Pinto-Medel, Begoña Oliver‐Martos, Jesús Ortega-Pinazo, Margarita Suardíaz, Lucía García Trujillo, Cristina Guijarro-Castro, Julián Benito‐León et al. · 2011 · PLoS ONE
91. Myelin matters: proteomic insights into white matter disorders
    Hauke B. Werner, Olaf Jahn · 2010 · Expert Review of Proteomics
92. CD46 Plasticity and Its Inflammatory Bias in Multiple Sclerosis
    Siobhán Ní Choileáin, Anne Astier · 2011 · Archivum Immunologiae et Therapiae Experimentalis
93. Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis
    Mingyuan Liu, Xiao-Jun Hou, Ping Zhang, Yong Hao, Yi-Ting Yang, Xiong-Feng Wu, Desheng Zhu, Y. Guan · 2013 · Molecular Biology Reports
94. Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis
    Alessandro S. Farias, Daniel Martins‐de‐Souza, Leandro Guimarães, Fernando Morandini Pradella, Adriel Santos Moraes, Gustavo Facchini, José C. Novello, Leonilda Maria Barbosa dos Santos · 2012 · PROTEOMICS
95. Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis
    Laura F. Dagley, Andrew Emili, Anthony Wayne Purcell · 2012 · PROTEOMICS - CLINICAL APPLICATIONS
96. Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis
    Madeleine H Sombekke, LF van der Voort, Jolijn J Kragt, JM Nielsen, H Guzel, Allerdien Visser, Cees B.M. Oudejans, J. Bart A. Crusius, Amado Salvador Peña, Hugo Vrenken et al. · 2011 · Multiple Sclerosis Journal
97. Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
    Jean‐Luc Dreyer · 2009 · Methods in molecular biology
98. Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis
    Sophie Buhelt, Rikke Lenhard Ratzer, Jeppe Romme Christensen, Lars Svend Börnsen, Finn Thorup Sellebjerg, Helle Bach Søndergaard · 2017 · Cytokine
99. Aggregated network centrality shows non-random structure of genomic and proteomic networks
    Anup Kumar Halder, Michał Denkiewicz, Kaustav Sengupta, Subhadip Basu, Dariusz Plewczyński · 2019 · Methods
100. Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition
     Fiona Blanco‐Kelly, Roberto Álvarez‐Lafuente, Antonio Alcina, María M. Abad‐Grau, V. De Las Heras, Miguel Lucas, Emilio G. de la Concha, Óscar Fernández, R Arroyo, Fuencisla Matesanz et al. · 2010 · Genes and Immunity